Status:
UNKNOWN
The Effect of Patient's Position After Intra-tympanic Injection on the Amount of Fluid in the Middle Ear
Lead Sponsor:
Tel-Aviv Sourasky Medical Center
Conditions:
Sudden Hearing Loss
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
During the regular protocol of Intra-tympanic injections of Dexamethasone to the middle ear due to Sudden Sensorineural Hearing Loss, the patients will be sitted once after the injection instead of ly...
Eligibility Criteria
Inclusion
- Patients diagnosed with Sudden Sensorineural Hearing Loss, treated using intra-tympanic injection of steroids to the middle ear
Exclusion
- Patients with abnormal sense of taste
- Middle or inner ear anomaly
- Eustachian tube dysfunction
Key Trial Info
Start Date :
August 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 31 2021
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT04449848
Start Date
August 1 2020
End Date
July 31 2021
Last Update
June 29 2020
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.